Current therapy of rheumatoid arthritis
Abstract
The well informed and well motivated patient with rheumatoid arthritis today has an excellent chance of avoiding serious disability and deformity. No available pharmacologic agent can permanently alter the course of the disease, and no pharmacologic agent can preclude the need for a balanced program emphasizing moderation, rest and constant attention to physical therapy. Early synovectomy is enjoying increasing popularity although the long-term benefits have yet to be established. The several drugs now undergoing trial hold little promise of materially altering the management of rheumatoid arthritis in the near future. The skills of physician, surgeon, and physiatrist must be brought to bear to provide optimal care.
Similar articles
-
What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?Best Pract Res Clin Rheumatol. 2001 Mar;15(1):171-85. doi: 10.1053/berh.2000.0132. Best Pract Res Clin Rheumatol. 2001. PMID: 11358421 Review.
-
Current management of rheumatoid arthritis.Br J Hosp Med. 1986 Jun;35(6):374-81. Br J Hosp Med. 1986. PMID: 3719205
-
Treatment of rheumatoid arthritis: unknown long-term effects.Prescrire Int. 2001 Apr;10(52):55-61. Prescrire Int. 2001. PMID: 11718162 Review.
-
Non-drug therapies in early rheumatoid arthritis.Best Pract Res Clin Rheumatol. 2009 Feb;23(1):103-16. doi: 10.1016/j.berh.2008.08.004. Best Pract Res Clin Rheumatol. 2009. PMID: 19233050 Review.
-
The treatment of rheumatoid arthritis as seen by a physiatrist.J Med Assoc State Ala. 1968 Jul;38(1):40-5. J Med Assoc State Ala. 1968. PMID: 5666519 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources